A 65-yr. old male who has multiple myeloma is currently rece…
A 65-yr. old male who has multiple myeloma is currently receiving monoclonal anti-CD38 immunotherapy (Daratumumab). Which of the following is used to treat reagent red cells in an effort to prevent interference of this drug with testing in the blood bank?
Read Details